Avid Bioservices Inc (CDMO)

[entdoc]

Realist, if you consider that the vast majority of oncologists have not heard of Bavituximab, why do you think it would be on the radar of any other specialists, like OB, ophthalmology, or even family practice? Maybe a handful of oncologist might remember having seen Bavi listed in a group of"hopeful" anti-cancer agents. Almost all MDs have been burned a few time too in chasing the dream. I don't post here because nothing new has happened in 16 months, but I remain invested in PPHM, and have even set aside a bit of cash throw in... (bad $$ after worse?)
we'll see.